Search the database for deliberate release of GM medicinal products
Displaying 1 - 2 of 2
|EU record number
|Company / Sponsor
|Only notified under the "contained use" procedure. Dossier submitted on 07/04/2017.
|Phase 1 clinical trial evaluation of two genetically modified vaccines against poliovirus
|Genetic modifications of the nOPV2 vaccine candidates aimed at stabilizing the genetic sequence against reversion compared to the Sabin-2 strain, nOPV2 candidate 1 (S2/cre5/S15domV/rec1/hifi3), nOPV2 candidate 2 (S2/S15domV/CpG40)
|Only notified under the "contained use" procedure. Dossier submitted on 09/06/1998.
|A phase II, multi-center, open label, randomized study to evaluate biodistribution and transmission, effectiveness and safety of two treatment regimens of Ad5CMV-p53 administered by intra-tumoral injections in 40 evaluable patients with advanced squamous